Tardio Jason
- SEC CIK
- 0001794698
No open-market purchases or sales filed in the past year.
Current role at each company
- IMUX Immunic, Inc.President and COOas of Jun 29, 2026
- OVID Ovid Therapeutics Inc.Chief Operating Officeras of Feb 26, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tardio Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMUX Immunic, Inc.
President and COO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 (view filing) | Jun 5 | 15 days | Tardio JasonPresident and COO | PPurchase | +12.5K | $0.79 | +$9.88K | New position12.5K after | Amended |
OVID Ovid Therapeutics Inc.
Chief Operating Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 (view filing) | Sep 12 | 2 days | Tardio JasonChief Operating Officer | SSale | −17.3K | $2.15 | −$37.3K | −100.0%0 after |